Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome

Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: میترا نیافر

کلمات کلیدی: Adiponectin, insulin resistance, metabolic syndrome, polycystic ovarian syndrome, women

نشریه: 13224 , 31 , 6 , 2015

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله میترا نیافر
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات غدد درون ریز
کد مقاله 58465
عنوان فارسی مقاله Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome
عنوان لاتین مقاله Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome
ناشر 2
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت http://www.ncbi.nlm.nih.gov/pubmed/25884893

خلاصه مقاله
hide/show

Abstract Objective: To examine the role of adiponectin as a biomarker of insulin resistance in polycystic ovary syndrome (PCOS). Background: PCOS is associated with metabolic syndrome, which correlates to increased cardiovascular risk in these patients. Adiponectin is decreased in obese individuals. Methods: Ninety women with PCOS (45 with and 45 without metabolic syndrome) were enrolled in this study. Anthropometric variables, serum concentrations of fasting glucose, insulin, triglycerides, lipoproteins, cholesterol, testosterone and adiponectin were measured in all patients. Insulin sensitivity was examined in all patients. Numerical values were analyzed by t-tests and categorical data were analyzed by Chi-square test. Multiple regression analyses were performed to detect the factors that contributed to insulin resistance. Results: Metabolic syndrome predicted insulin resistance in PCOS patients. Serum adiponectin levels were suppressed in insulin resistant compared to insulin sensitive patients (10.7 ± 4.3 mg/mL, p50.001). Multiple linear regression analysis revealed for every 1 mg increase in adiponectin, insulin sensitivity index increases by 0.1 (p¼0.016). Serum testosterone failed to correlate with insulin sensitivity. Conclusion: Serum adiponectin levels were suppressed in patients with both metabolic syndrome and insulin resistance. This protein could be used as a biomarker to distinguish the patients at a higher risk of diabetes and cardiovascular morbidity.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
میترا نیافراول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
09513590.2015.1008445.pdf1395/05/11164172دانلود
09513590.2015.1008445.pdf1395/05/11164172دانلود